Shengjing Hospital of China Medical University
Shenyang, Liaoning, 110004, China
NCT Number: NCT06687044
During pregnancy, the physical and psychological changes of pregnant women, hyperemesis gravidarum, uterine compression, frequent urination, hip or pelvic pain, back pain, leg cramps, gastroesophageal reflux, changes in mental state, and even changes in lifestyle, habits and tastes may affect the sleep of pregnant women. Due to the coexistence of physiological, psychological, social and other complex factors during pregnancy, the incidence of sleep disorders in pregnant women is relatively high, up to 50%, and shows an increasing trend with the increase of gestational week. Not only seriously affect the quality of life of pregnant women, but also may lead to a variety of pregnancy complications, and even lead to adverse pregnancy outcomes. Therefore, early identification, timely diagnosis and treatment of sleep disorders during pregnancy are important measures to improve or even reverse adverse pregnancy outcomes. Although sleep disorders are more common and seriously harmful during pregnancy, people lack of understanding and attention to such diseases, and often regard them as normal clinical manifestations of pregnancy and neglect diagnosis and treatment.
Studies have shown that maternal sleep disorders are associated with hypertensive disorders during pregnancy, preterm birth, and gestational diabetes. Current research objects mainly focus on single pregnancy, twin related research is less.
The purpose of this study is to explore the perinatal sleep health of pregnant women with twin pregnancies, reduce the complications of pregnant women with twin pregnancies and improve the pregnancy outcomes of mothers and infants by improving sleep quality.
Interested in participating?
Request Info18 year–45 year
Female
Interventional
Not applicable
Shenyang, Liaoning, 110004, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(1) Pregnant women aged 18-45 years. (2) Diagnosed with single or twin pregnancy within 12 weeks of pregnancy, report sleep quality problems, agree to participate in the study and sign the informed consent -
Exclusion criteria
Have a prior serious underlying medical condition (e.g., diabetes, heart disease), mental illness, or other serious sleep disorder
-
Go to bed before 23pm
Avoid drugs, alcohol, caffeine, and nicotine
Listen to 30 minutes of soothing music every night for 8 weeks
The principles of sleep hygiene are discussed, but without the application of stimulus control or sleep restriction
Time frame: From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)
Pregnancy induced hypertension (PIH) is hypertension that occurs after 20 weeks of gestation in women with previously normal blood pressure.
Time frame: From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)
Gestational diabetes mellitus (GDM) is defined as glucose intolerance of variable degree with onset or first recognition during pregnancy
Time frame: From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)
Preterm labor is parturition that occurs when birth occurs between 28 weeks of gestation and 37 weeks
Time frame: From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)
Neonatal NICU occupancy rate
Jun Wei
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07263490
ART, Abruptio Placentae
Copenhagen, Denmark
View Trial DetailsNCT06054841
Cardiovascular Diseases, Cervical Dysplasia
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05543265
Anxiety Disorders, Body Weight
Boston, Massachusetts, United States
View Trial DetailsNCT05835596
Cardiovascular Diseases, Diabetes Mellitus
Oslo, Norway
View Trial Details